EurekAlert! -
10 Aug 2018 06:00
(NIH/National Institute of Allergy and Infectious Diseases) Despite promising advances, important scientific questions remain unanswered in the effort to develop a safe and effective Ebola vaccine, according to members of an international Ebola research consortium. In a Viewpoint published in The Lancet, the experts review the current field of Ebola vaccine candidates and clinical trials and highlight key gaps in knowledge that need to be addressed by future research.
Share this Article